Imperative announces randomized trial assessing aspiration thrombectomy in M2 occlusion strokes
Read the original on Neuro News International (opens in a new tab)
Media contacts
Investor Contact
Phil Nalbone
VP of Corporate Development and Investor Relations
In the media
Medical Product Outsourcing
Promising results reported from Imperative Care’s Symphony Thrombectomy System study
Endovascular Today
Imperative Care presents Symphony Thrombectomy System pivotal trial in acute PE
Diagnostic & International Cardiology